Status:
COMPLETED
Nerve Growth Factor in Chronic Pancreatitis
Lead Sponsor:
Virginia Commonwealth University
Collaborating Sponsors:
Stanford University
Conditions:
Chronic Pancreatitis
Eligibility:
All Genders
18-70 years
Brief Summary
This study is to understand the role of nerve growth factor(NGF) and other cytokines in the pancreatic fluid of patients with chronic pancreatitis. Hypothesis: 1. Pain does not correlate with change...
Eligibility Criteria
Inclusion
- Patients with established CP and none of the exclusion criteria mention below.
Exclusion
- Failure to obtain consent.
- Any comorbid condition with expected survival \< 1 year.
- Patients with pacemaker, implanted metallic prosthesis or other contraindications to do MRCP.
- Patients \< 18 years of age at time of consent
Key Trial Info
Start Date :
February 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2011
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT01255917
Start Date
February 1 2008
End Date
August 1 2011
Last Update
March 7 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Virginia Commonwealth University Medical Center
Richmond, Virginia, United States, 23298